|
SNX15 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66422431391311E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.09690034832965E-13 |
| Normal-vs-Stage2 |
1.69389999999936E-05 |
| Normal-vs-Stage3 |
1.00660002555486E-09 |
| Normal-vs-Stage4 |
6.42159658781338E-11 |
| Stage1-vs-Stage2 |
3.213000E-01 |
| Stage1-vs-Stage3 |
4.217600E-01 |
| Stage1-vs-Stage4 |
2.971800E-01 |
| Stage2-vs-Stage3 |
2.082000E-01 |
| Stage2-vs-Stage4 |
1.294020E-01 |
| Stage3-vs-Stage4 |
7.926200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.33146835171283E-15 |
| Normal-vs-AfricanAmerican |
2.804300E-04 |
| Normal-vs-Asian |
1.57260000022141E-07 |
| Caucasian-vs-AfricanAmerican |
5.878400E-01 |
| Caucasian-vs-Asian |
2.695200E-01 |
| AfricanAmerican-vs-Asian |
3.158400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.11400033431642E-10 |
| Normal-vs-Female |
1.66622271535743E-12 |
| Male-vs-Female |
6.451600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.69608771471985E-12 |
| Normal-vs-Age(41-60Yrs) |
6.15120177016593E-11 |
| Normal-vs-Age(61-80Yrs) |
1.29230004475289E-09 |
| Normal-vs-Age(81-100Yrs) |
5.008900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.461800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.963200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.508200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.941600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.900600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.258800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.470200E-01 |
| Classical-VS-Follicular |
2.155800E-01 |
| Classical-VS-Other |
6.411000E-01 |
| Classical-VS-Normal |
3.72823993899374E-12 |
| Tall-VS-Follicular |
9.662600E-01 |
| Tall-VS-Other |
5.411400E-01 |
| Tall-VS-Normal |
2.19249995936366E-09 |
| Follicular-VS-Other |
4.461600E-01 |
| Follicular-VS-Normal |
1.13400000500974E-09 |
| Other-VS-Normal |
3.202300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.0411995971823E-10 |
| Normal-vs-N1 |
1.88737914186277E-14 |
| N0-vs-N1 |
2.997100E-03 |
|
|
